Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond
- PMID: 14670831
- DOI: 10.1161/01.RES.0000103862.26506.3D
Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond
Abstract
The cardiovascular complications of diabetes represent the leading cause of morbidity and mortality in affected subjects. The impact of hyperglycemia may be both direct and indirect: indirect consequences of elevated blood glucose lead to generation of advanced glycation endproducts, the products of nonenzymatic glycation/oxidation of proteins/lipids that accumulate in the vessel wall, and are signal transduction ligands for Receptor for AGE (RAGE). Although enhanced in diabetes, AGE accumulation also occurs in euglycemia and aging, albeit to lower degrees, driven by oxidant stress and inflammation. In hyperglycemia, production of 3-deoxyglucosone, at least in part via the polyol pathway, provides an amplification loop to sustain AGE generation, oxidant stress, and vascular activation. Furthermore, recruitment of inflammatory cells bearing S100/calgranulins, also ligands for RAGE, augments vascular dysfunction. We hypothesize that activation of RAGE is a final common pathway that transduces signals from these diverse biochemical and molecular species, leading to cardiovascular perturbation. Ultimately, these pathways synergize to construct a scaffold on which the complications of diabetes in the vasculature and heart may be built. We propose that antagonism of RAGE will provide a unique means to dismantle this scaffold and, thereby, suppress initiation/progression of vascular disease and cardiac dysfunction that accompany diabetes and aging.
Similar articles
-
The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.Trends Cardiovasc Med. 2005 Oct;15(7):237-43. doi: 10.1016/j.tcm.2005.08.003. Trends Cardiovasc Med. 2005. PMID: 16226677 Review.
-
Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging.Curr Mol Med. 2007 Dec;7(8):699-710. Curr Mol Med. 2007. PMID: 18331228 Review.
-
Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.Nat Clin Pract Endocrinol Metab. 2008 May;4(5):285-93. doi: 10.1038/ncpendmet0786. Epub 2008 Mar 11. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18332897 Review.
-
RAGE: a journey from the complications of diabetes to disorders of the nervous system - striking a fine balance between injury and repair.Restor Neurol Neurosci. 2005;23(5-6):355-65. Restor Neurol Neurosci. 2005. PMID: 16477098 Review.
-
Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing.Endocrinol Metab Clin North Am. 2006 Sep;35(3):511-24, viii. doi: 10.1016/j.ecl.2006.06.003. Endocrinol Metab Clin North Am. 2006. PMID: 16959583 Review.
Cited by
-
Mechanisms and Perspectives of Sodium-Glucose Co-transporter 2 Inhibitors in Heart Failure.Front Cardiovasc Med. 2021 Feb 10;8:636152. doi: 10.3389/fcvm.2021.636152. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33644138 Free PMC article. Review.
-
Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.Int J Mol Sci. 2019 Aug 13;20(16):3942. doi: 10.3390/ijms20163942. Int J Mol Sci. 2019. PMID: 31412635 Free PMC article.
-
[Current concepts of diabetic atherogenesis].Clin Res Cardiol. 2006 Jan;95 Suppl 1:i1-6. doi: 10.1007/s00392-006-1114-z. Clin Res Cardiol. 2006. PMID: 16598535 Review. German.
-
The Role of Hyperglycemia in Endometrial Cancer Pathogenesis.Cancers (Basel). 2020 May 8;12(5):1191. doi: 10.3390/cancers12051191. Cancers (Basel). 2020. PMID: 32397158 Free PMC article. Review.
-
Chronic exercise training prevents coronary artery stiffening in aortic-banded miniswine: role of perivascular adipose-derived advanced glycation end products.J Appl Physiol (1985). 2019 Sep 1;127(3):816-827. doi: 10.1152/japplphysiol.00146.2019. Epub 2019 Jul 11. J Appl Physiol (1985). 2019. PMID: 31295062 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources